PARSABIV is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Amgen Inc. The primary component is Etelcalcetide Hydrochloride.
| Product ID | 55513-740_012ce6ec-5707-49fa-9e39-6932948c2283 |
| NDC | 55513-740 |
| Product Type | Human Prescription Drug |
| Proprietary Name | PARSABIV |
| Generic Name | Etelcalcetide |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2017-04-03 |
| Marketing Category | NDA / NDA |
| Application Number | NDA208325 |
| Labeler Name | Amgen Inc |
| Substance Name | ETELCALCETIDE HYDROCHLORIDE |
| Active Ingredient Strength | 3 mg/.5mL |
| Pharm Classes | Calcium-sensing Receptor Agonist [EPC],Increased Calcium-sensing Receptor Sensitivity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2017-04-03 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA208325 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2017-04-03 |
| Marketing Category | NDA |
| Application Number | NDA208325 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2017-04-03 |
| Ingredient | Strength |
|---|---|
| ETELCALCETIDE HYDROCHLORIDE | 2.5 mg/.5mL |
| SPL SET ID: | cd270093-c6a8-4596-a4ab-e6aa0a2c8a0c |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 55513-740 | PARSABIV | etelcalcetide |
| 55513-741 | PARSABIV | etelcalcetide |
| 55513-742 | PARSABIV | etelcalcetide |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() PARSABIV 87038725 5438851 Live/Registered |
Amgen Inc. 2016-05-16 |
![]() PARSABIV 86523783 5428730 Live/Registered |
Amgen Inc. 2015-02-04 |